March 2017

ACT-AD Hosts Webinar on Symptomatic Relief for Alzheimer’s Disease

On March 15, ACT-AD hosted a webinar on symptomatic relief for Alzheimer’s disease. The one-hour webinar featured expert perspectives on the burden of Alzheimer’s disease, highlighted advances in neurobiology, and provided updates on recent clinical trial development activities to improve the treatment of Alzheimer’s disease symptoms. Find a full recap of the webinar here.

Diabetes Drug May Assist in Detection And Treatment of Alzheimer’s Disease

A recent study in Translational Research and Clinical Interventions discovered treatment with pramlintide, a diabetes drug, improved learning and memory function in Alzheimer’s patients and decreases the disease’s pathology in their brains. The study also found that their discovery may also lead to the creation of a blood test to diagnose Alzheimer’s disease. To learn more about the study, go here.

Discovery of a Genetic Variant’s Impact on Aging Could Offer Treatments for Age-Associated Brain Disorders

Researchers at Columbia University Medical Center found a common genetic variant that begins to affect brain aging in older adults. The discovery of the gene, TMEM106B, could lead to a biomarker for assessing anti-aging interventions and potential targets for preventing or treating age-related brain disorders. To learn more about the findings, go here.

Daily Tea Consumption May Reduce Risk of Cognitive Decline, Researchers Say

Researchers at the National University of Singapore recently conducted a study that found regular consumption of tea reduces the risk of cognitive decline in older adults by 50 percent and 86 percent in those who are genetically predisposed to the disease. The team found that the protective qualities of the tea were not limited to a particular type, but depended on whether the tea was brewed directly from tea leaves. The researchers say the benefits of tea could be due to the bioactive compounds found in the tea leaves, which exhibit anti-inflammatory and antioxidant properties that protect the brain. To learn more about the study, go here.

NIA Will Host Meeting on Shaping Recruitment Strategies for Alzheimer’s Disease, April 28

The National Institute on Aging will host a meeting to examine solutions to recruitment challenges in Alzheimer’s disease and related dementias. The meeting will allow stakeholders to provide input that will assist in shaping a national recruitment strategy for Alzheimer’s disease and related dementias, which is slated for a late summer 2017 release. The meeting will be streamed live. More information about the meeting will be provided on NIA’s website soon.